The influence of citrate, EDTA, and heparin anticoagulants to human plasma LC-MS lipidomic profiling

Metabolomics

Volumn 9, Issue 2, 2013, Pages 337-348

  Gonzalez Covarrubias, Vanessa ^a,b   Dane, Adrie ^a,b   Hankemeier, Thomas ^a,b   Vreeken, Rob J ^a,b  

^a NETHERLANDS METABOLOMICS CENTRE   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Anticoagulant; Citrate; EDTA; Heparin; LC MS; Lipidomics

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; EDETIC ACID; HEPARIN; LIPID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOETHANOLAMINE; PHOSPHOLIPID; TRIACYLGLYCEROL;

ARTICLE; BLOOD PH; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; FEMALE; HUMAN; HUMAN CELL; IONIC STRENGTH; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPIDOMICS; LIQUID CHROMATOGRAPHY; PHYSICAL CHEMISTRY; STANDARD;

EID: 84875497782     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-012-0450-4     Document Type: Article

References (24)

1. Barton, R. H., Waterman, D., Bonner, F. W., Holmes, E., Clarke, R., Nicholson, J. K., et al. (2009). The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies. Molecular BioSystems, 6(1), 215-224. doi: 10. 1039/b907021d.
2. Bergheanu, S. C., Reijmers, T., Zwinderman, A. H., Bobeldijk, I., Ramaker, R., Liem, A.-H., et al. (2008). Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: Investigating differential effects among statins. Current Medical Research and Opinion, 24(9), 2477-2487. doi: 1185/03007990802321709.
3. Bligh, E., & Dyer, W. (1959). A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology, 37, 911-917.
4. Christensen, J. M., & Stalker, D. (1991). Ibuprofen piconol hydrolysis invitro in plasma, whole-blood, and serum using different anticoagulants. Journal of Pharmaceutical Sciences, 80(1), 29-31. doi: 10. 1002/jps. 2600800108.
5. Evans, M. J., Livesey, J. H., Ellis, M. J., & Yandle, T. G. (2001). Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clinical Biochemistry, 34(2), 107-112.
6. Graessler, J., Schwudke, D., Schwarz, P. E. H., Herzog, R., Shevchenko, A., & Bornstein, S. R. (2009). Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One, 4(7), e6261.
7. Gross, Richard. W., & Han, X. (2011). Lipidomics at the interface of structure and function in systems biology. Chemistry & Biology, 18(3), 284-291.
8. Hu, C., van Dommelen, J., van der Heijden, R., Spijksma, G., Reijmers, T. H., Wang, M., et al. (2008). RPLC-ion-trap-FTMS method for lipid profiling of plasma: Method validation and application to p53 mutant mouse model. Journal of Proteome Research, 7(11), 4982-4991. doi: 10. 1021/pr800373m.
9. Jessome, L. L., & Volmer, D. A. (2006). Ion suppression: A major concern in mass spectrometry. LCGC North America, 24, 498-510.
10. Johnstone, I. B. (1993). The importance of accurate citrate to blood ratios in the collection of canine blood for hemostatic testing. Canadian Veterinary Journal (Revue Veterinaire Canadienne), 34(10), 627-629.
11. Kirschner, L. B. (1958). The cation content of phospholipids from swine erythrocytes. Journal of General Physiology, 42(2), 231-241.
12. Mastovska, K., Lehotay, S. J., & Anastassiades, M. (2005). Combination of analyte protectants to overcome matrix effects in routine GC analysis of pesticide residues in food matrixes. Analytical Chemistry, 77(24), 8129-8137. doi: 10. 1021/ac0515576.
13. Matuszewski, B. K. (2006). Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 830(2), 293-300. doi: 10. 1016/j. jchromb. 2005. 11. 009.
14. Mei, H., Hsieh, Y. S., Nardo, C., Xu, X. Y., Wang, S. Y., Ng, K., et al. (2003). Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: Application to drug discovery. Rapid Communications in Mass Spectrometry, 17(1), 97-103. doi: 10. 1002/rcm. 876.
15. Mori, T. A., Mas, E., Barden, A. E., Zahra, P., & Croft, K. D. (2012). Measurement of resolvins and protectins using liquid chromatography-tandem mass spectrometry: Comparison of plasma and serum levels in humans. ISSFAL Conference: Poster, Vancouver, Canada.
16. Peoples, M. C., Halquist, M. S., Ismaiel, O., El-Mammli, M. Y., Shalaby, A., & Karnes, H. T. (2008). Assessment of matrix effects and determination of niacin in human plasma using liquid-liquid extraction and liquid chromatography-tandem mass spectrometry. Biomedical Chromatography, 22(11), 1272-1278. doi: 10. 1002/bmc. 1057.
17. Quehenberger, O., & Dennis, E. A. (2011). The human plasma lipidome. New England Journal of Medicine, 365(19), 1812-1823. doi: 10. 1056/NEJMra1104901.
18. Stein, P. E., & Goodier, D. W. (1986). Effect of in vitro sodium citrate anticoagulant on results of arterial blood gas analysis. Journal of Clinical Pathology, 39(9), 1046.
19. Szymańska, E., van Dorsten, F., Troost, J., Paliukhovich, I., van Velzen, E., Hendriks, M., et al. (2011). A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intake. Metabolomics, 1-13. doi: 10. 1007/s11306-011-0384-2.
20. Taylor, P. J. (2005). Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clinical Biochemistry, 38(4), 328-334. doi: 10. 1016/j. clinbiochem. 2004. 11. 007.
21. Viswanathan, C. T., Bansal, S., Booth, B., DeStefano, A. J., Rose, M. J., Sailstad, J., et al. (2007). Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays. Pharmaceutical Research, 24(10), 1962-1973. doi: 10. 1007/s11095-007-9291-7.
22. Xia, J., Psychogios, N., Young, N., & Wishart, D. S. (2009). MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Research, 37(suppl 2), W652-W660. doi: 10. 1093/nar/gkp356.
23. Yi, J., Craft, D., & Gelfand, C. A. (2011). Minimizing preanalytical variation of plasma samples by proper blood collection and handling. Methods in Molecular Biology, 728(2), 137-149. doi: 10. 1007/978-1-61779-068-3_8.
24. Yu, Z., Kastenmaller, G., He, Y., Belcredi, P., Maller, G., Prehn, C., et al. (2011). Differences between human plasma and serum metabolite profiles. PLoS One, 6(7), e21230.